Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
In March 2026, topline results from the TRANSCEND-T2D-1 trials showed that participants with Type 2 diabetes achieved an average A1C reduction of up to 2.0% and lost nearly 17% of their body weight over 40 weeks
The results demonstrated a significant reduction in the risk of developing POAG in the patients taking a GLP-1RA compared to those using alternate weight loss medications
Resistance exercise reverses aging in human skeletal muscle
How does weight management impact diverticulitis
Alternative weight management strategies during this transition period should be explored
How to Order
US$ 21.50
US$ 21.78
US$ 22.80
US$ 21.13
US$ 24.77
US$ 28.56
